Search Results - "Gulati, Shuchi"

Spectrum of Presentations and Management Strategies in Renal Angiomyolipoma.

Authors: Khaddam, Sinan Gulati, Shuchi

Source: Journal of Kidney Cancer & VHL. 2022, Vol. 9 Issue 1, p42-47. 6p.

Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma.

Authors: Gulati, Shuchi Barata, Pedro C. Elliott, Andrew et al.

Source: Journal of Clinical Investigation. 7/15/2024, Vol. 134 Issue 14, p1-11. 11p.

Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles.

Authors: Barata, Pedro Gulati, Shuchi Elliott, Andrew et al.

Source: Journal of Clinical Investigation. 6/3/2024, Vol. 134 Issue 11, p1-9. 9p.

Anticoagulant Therapy for Cancer-Associated Thrombosis: A Cost-Effectiveness Analysis.

Authors: Gulati, Shuchi Eckman, Mark H.

Source: Annals of Internal Medicine. Jan2023, Vol. 176 Issue 1, p1-9. 9p. 1 Diagram, 4 Charts, 2 Graphs.

Ocular Adnexal Lymphoma Presenting with Visual Loss.

Authors: Gulati, Shuchi Corrêa, Zélia M. Karim, Nagla et al.

Source: North American Journal of Medical Sciences. Jan2016, Vol. 8 Issue 1, p56-60. 5p.

Diabetes Insipidus: An Unusual Presentation of Adenocarcinoma of the Lung in a Patient with no Identifiable Lung Mass.

Authors: Gulati, Shuchi Kiefer, Christoper Karim, Nagla Abdel

Source: North American Journal of Medical Sciences. Oct2015, Vol. 7 Issue 10, p476-479. 4p.

Systemic therapy and COVID19: Immunotherapy and chemotherapy.

Authors: Gulati, Shuchi Muddasani, Ramya Gustavo Bergerot, Paulo et al.

Source: Urologic Oncology. Apr2021, Vol. 39 Issue 4, p213-220. 8p.

Phase 1 dose-finding study of metformin in combination with concurrent cisplatin and radiotherapy in patients with locally advanced head and neck squamous cell cancer.

Authors: Gulati, Shuchi Desai, Janki Palackdharry, Sarah M. et al.

Source: Cancer (0008543X). Jan2020, Vol. 126 Issue 2, p354-362. 9p.

Order of curricular interventions in recognition of haematopathological images.

Authors: Gulati, Shuchi Wasser, Thomas Donato, Anthony A

Source: Medical Education. Nov2015, Vol. 49 Issue 11, p1140-1141. 2p.

Subjects: Higher education, Adults, Curriculum, Study & teaching of medicine, Teaching methods, Blood testing, Blood diseases, Digital diagnostic imaging, Hematopoietic system

Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma.

Authors: Monda, Steven M. Carney, Benjamin W. May, Allison M. et al.

Source: BJU International. Feb2025, Vol. 135 Issue 2, p269-278. 10p.

Pathological concordance rate and outcomes by subtype in advanced papillary renal cell carcinoma.

Authors: Tripathi, Abhishek Tangen, Catherine M. Plets, Melissa et al.

Source: BJU International. Oct2024, Vol. 134 Issue 4, p596-601. 6p.

Phase-1 Study of Metformin in Combination with Concurrent Cisplatin and Radiotherapy in Patients with Locally Advanced Head and Neck Cancer

Authors: Gulati, Shuchi

Committee Members: Chen, Aimin

URL: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1593171585877322

Coinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.

Authors: Satyanarayana, Gowri Enriquez, Kyle T Sun, Tianyi et al.

Source: Open Forum Infectious Diseases. Mar2022, Vol. 9 Issue 3, p1-10. 10p.

COVID‐19 pandemic and impact on cancer clinical trials: An academic medical center perspective.

Authors: Marcum, Michelle Kurtzweil, Nicky Vollmer, Christine et al.

Source: Cancer Medicine. Sep2020, Vol. 9 Issue 17, p6141-6146. 6p.

Adjuvant Everolimus in Patients with Completely Resected, Very High-risk Renal Cell Carcinoma of Clear Cell Histology: Results from the Phase 3 Placebo-controlled SWOG S0931 (EVEREST) Trial.

Authors: Lara, Primo N. Tangen, Catherine Heath, Elisabeth I. et al.

Source: European Urology. Sep2024, Vol. 86 Issue 3, p258-264. 7p.

AI-discovered cellular morphometric biomarkers in needle biopsy of prostate cancer predict neoadjuvant androgen deprivation therapy response and enable therapeutic targeting of mTOR in androgen deprivation therapy-resistant tumors.

Authors: Yan, Hong Mao, April W. Li, Dan et al.

Source: Cancer Letters. Jun2026, Vol. 647, pN.PAG-N.PAG. 1p.

THE DISTRIBUTION OF MUTATIONS ACROSS TUMOR SIZE IN CCRCC AND THEIR PROGNOSTIC IMPORTANCE IN SMALL MASSES.

Authors: Monda, Steven Carney, Benjamin Gulati, Shuchi et al.

Source: Urologic Oncology. Mar2024:Supplement, Vol. 42, pS7-S7. 1p.

Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC).

Authors: Mar, Nataliya Dwabe, Sami Baranda, Marlon N. et al.

Source: Clinical Genitourinary Cancer. Apr2024, Vol. 22 Issue 2, p217-223. 7p.

Molecular and Metabolic Subtypes in Sporadic and Inherited Clear Cell Renal Cell Carcinoma.

Authors: Czyzyk-Krzeska, Maria F. Landero Figueroa, Julio A. Gulati, Shuchi et al.

Source: Genes. Mar2021, Vol. 12 Issue 3, p388-388. 1p.

Genome-wide variation in cell-free DNA end motif entropy predicts immunotherapy response in head and neck cancer.

Authors: Bandaru R Fu H Zheng H et al.

Source: The Journal of clinical investigation [J Clin Invest] 2026 May 19. Date of Electronic Publication: 2026 May 19.

Publication Type: Journal Article

Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE